Garg, Aakriti <br/><br/>
Risk and Benefit Profile of Dulaglutide in Established Therapeutic Indication.  [electronic resource] 

 -  Current drug safety  2018 
 - 165-170 p.  digital 
<br/><br/> Publication Type: Journal Article; Systematic Review 
<br/><br/><label>ISSN: </label>2212-3911 
<br/><br/><label>Standard No.: </label>10.2174/1574886313666180601082412  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Diabetes Mellitus, Type 2--drug therapy<br/>Disease Progression<br/>Glucagon-Like Peptides--adverse effects<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Immunoglobulin Fc Fragments--adverse effects<br/>Recombinant Fusion Proteins--adverse effects<br/>Treatment Outcome